CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 144 Insider Sale of Securities
- 4 Planned sale SVP, General Counsel sold 2,666 shares at $360.00 ($959,760)
- 4 Planned sale Chief Executive Officer sold 240,810 shares at an average $359.12 ($86,480,472)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 1,157 shares at $312.72 ($361,811)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale SVP, General Counsel sold 1,044 shares at $323.69 ($337,932)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, General Counsel sold 1,669 shares at $325.00 ($542,425)
- 4 Planned sale Chief Executive Officer sold 109,713 shares at an average $315.28 ($34,590,855)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 64,628 shares at an average $312.00 ($20,163,907)
- 4 Planned sale Chief Executive Officer sold 283,154 shares at an average $315.56 ($89,351,598)
- 4 Planned sale Chief Executive Officer sold 145,861 shares at an average $305.95 ($44,626,424)
- 4 Planned sale Chief Executive Officer sold 60,218 shares at an average $303.18 ($18,256,808)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, General Counsel sold 664 shares at $302.46 ($200,833)
Page 2 of 64 · 1,277 filings